Midcareer K24 Award for Mentoring and Patient-Oriented Research
职业生涯中期 K24 指导和以患者为导向的研究奖
基本信息
- 批准号:10618740
- 负责人:
- 金额:$ 20.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-01 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:Absence of pain sensationAccelerationAffectAnimalsBehavior TherapyBenefits and RisksCaringCharacteristicsCocaineDataData SetDevelopmentDiseaseEcological momentary assessmentElderlyEnrollmentEventFailureFemaleFundingGenderHIVHealthcare SystemsHeroinHourHumanInterventionInterviewLongitudinal cohort studyMental HealthMentorsMethamphetamineMethamphetamine overdoseMid-Career Clinical Scientist Award (K24)ModelingMorbidity - disease rateMotivationNaloxoneNational Institute of Drug AbuseNeuropathyOpioidOpioid AnalgesicsOverdosePainPain NaturePain ResearchPain intensityPain managementPalliative CareParticipantPatientsPeripheral Nervous System DiseasesPersonsPharmaceutical PreparationsPoisoningPostoperative PeriodPrimary CareQualitative MethodsReadingReportingResearchResearch PersonnelRewardsRiskSan FranciscoScienceSelf CareSelf ManagementSocial isolationSourceStimulantTimeToxic effectTrainingVoicecareerchronic painchronic pain patientclinical practicecohortexperienceexperimental studyfaculty mentorimplementation scienceimprovedmethamphetamine effectmethamphetamine usemortalitynon-cancer chronic painnovelnovel strategiesopioid useoverdose deathpainful neuropathypatient orientedpatient oriented researchpharmacologicpleasurepoor health outcomeprescription opioidreduced substance useresponsesocialstimulant usesubstance usesuicide mortalitytransmission processtrial designviral transmission
项目摘要
Project Summary/Abstract
This K24 award will support the candidate’s development as a mentor and substance use investigator, while
completing a novel study of the use of non-prescribed stimulants in the self-care of chronic pain, particularly
among people living with HIV and neuropathic pain. The candidate will complete training in mentoring through
differentness to further enhance his ability to mentor trainees underrepresented in science, while also
developing and delivering a training targeted for mentors not underrepresented, in order to improve the
pipeline of senior mentors who can effectively mentor underrepresented trainees. He will also enhance his
abilities to conduct substance use research by obtaining additional training in implementation science,
ecological momentary assessment, adaptive trial design, and pain research. He will undertake directed reading
with experts in pain research and in mentoring. In addition, the candidate will pursue new research to examine
the phenomenon of non-prescribed stimulant use self-care of chronic pain. The candidate will enroll 50 people
living with HIV and neuropathic pain who report methamphetamine use for pain self-care for 6 months of
ecological momentary assessments, to determine the relationship between use and functional pain. The
candidate will conduct qualitative interviews with 30 of the participants to explore the nature of the pain and
relationship between physical and social pain, as well as the perceived risks and benefits to methamphetamine
use. Finally, he will compare those who do not use stimulants, who use stimulants for pain, and who use
stimulants for other reasons from his longitudinal cohort study of patients with chronic pain to establish
longitudinal effects of methamphetamine use for pain self-care.
项目摘要/摘要
该K24奖将支持候选人作为精神和药物使用调查员的发展,而
完成一项关于在慢性疼痛的自我护理中使用非处方刺激剂的新研究,尤其是
在患有艾滋病毒和神经性疼痛的人中。候选人将通过
不同之处,以进一步增强他在科学领域的精神培训能力不足的能力,同时也
为了改善未代表性的导师,开发和提供针对导师的培训
高级导师的管道有效地代表人数不足。他还将增强他的
通过获得实施科学方面的额外培训来进行药物使用研究的能力,
生态瞬时评估,适应性试验设计和疼痛研究。他将进行定向阅读
具有疼痛研究和心理研究专家。此外,候选人将进行新的研究以进行考试
非处方刺激物的现象使用了慢性疼痛的自我保健。候选人将注册50人
患有艾滋病毒和神经性疼痛的人报告甲基苯丙胺用于疼痛自我护理6个月
生态瞬间评估,以确定使用与功能疼痛之间的关系。
候选人将对30名参与者进行定性访谈,以探索疼痛的性质和
身体和社会痛苦之间的关系,以及甲基苯丙胺的风险和益处
使用。最后,他将比较那些不使用兴奋剂,使用兴奋剂痛苦并使用的人
由于他的纵向队列研究的其他原因,刺激因素是慢性疼痛患者的
甲基苯丙胺用于疼痛自我护理的纵向作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PHILLIP O COFFIN其他文献
PHILLIP O COFFIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PHILLIP O COFFIN', 18)}}的其他基金
Leveraging Psychological Autopsies to Accelerate Research into Stimulant Overdose Mortality
利用心理尸检加速兴奋剂过量死亡率的研究
- 批准号:
10387934 - 财政年份:2021
- 资助金额:
$ 20.25万 - 项目类别:
Leveraging Psychological Autopsies to Accelerate Research into Stimulant Overdose Mortality
利用心理尸检加速兴奋剂过量死亡率的研究
- 批准号:
10664991 - 财政年份:2021
- 资助金额:
$ 20.25万 - 项目类别:
PRIME: PrEP Intervention for people who Inject MEthamphetamine
PRIME:针对注射甲基苯丙胺患者的 PrEP 干预
- 批准号:
10223260 - 财政年份:2020
- 资助金额:
$ 20.25万 - 项目类别:
PRIME: PrEP Intervention for people who Inject MEthamphetamine
PRIME:针对注射甲基苯丙胺患者的 PrEP 干预
- 批准号:
10655538 - 财政年份:2020
- 资助金额:
$ 20.25万 - 项目类别:
PRIME: PrEP Intervention for people who Inject MEthamphetamine
PRIME:针对注射甲基苯丙胺患者的 PrEP 干预
- 批准号:
10424546 - 财政年份:2020
- 资助金额:
$ 20.25万 - 项目类别:
Mirtazapine for methamphetamine use disorder: drug-drug interaction study
米氮平治疗甲基苯丙胺使用障碍:药物相互作用研究
- 批准号:
9983371 - 财政年份:2020
- 资助金额:
$ 20.25万 - 项目类别:
PRIME: PrEP Intervention for people who Inject MEthamphetamine
PRIME:针对注射甲基苯丙胺患者的 PrEP 干预
- 批准号:
10054139 - 财政年份:2020
- 资助金额:
$ 20.25万 - 项目类别:
Repeated-dose behavioral intervention to reduce opioid overdose: a two-site randomized-controlled efficacy trial
重复剂量行为干预减少阿片类药物过量:一项两中心随机对照疗效试验
- 批准号:
9896799 - 财政年份:2018
- 资助金额:
$ 20.25万 - 项目类别:
Repeated-dose behavioral intervention to reduce opioid overdose: a two-site randomized-controlled efficacy trial
重复剂量行为干预减少阿片类药物过量:一项两中心随机对照疗效试验
- 批准号:
10374101 - 财政年份:2018
- 资助金额:
$ 20.25万 - 项目类别:
Mid-Career Award in Patient-Oriented Substance Use Research Addressing Opioids, Chronic Pain, and HIV
针对阿片类药物、慢性疼痛和艾滋病毒的以患者为导向的药物使用研究中的职业生涯中期奖
- 批准号:
9981708 - 财政年份:2016
- 资助金额:
$ 20.25万 - 项目类别:
相似国自然基金
考虑水平、垂直加速度影响的地震滑坡危险性快速评价方法研究
- 批准号:42307269
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
剪切场下熔体真实流动状态调控及其对结晶影响的研究
- 批准号:51803192
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
射电源结构效应对太阳系质心加速度估计的影响
- 批准号:11603060
- 批准年份:2016
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
强震动观测台站建筑物对强地面运动的影响及其处理方法研究
- 批准号:51608098
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
封装效应对微加速度计稳定性影响的基础问题研究
- 批准号:U1530132
- 批准年份:2015
- 资助金额:63.0 万元
- 项目类别:联合基金项目
相似海外基金
Causes and Downstream Effects of 14-3-3 Phosphorylation in Synucleinopathies
突触核蛋白病中 14-3-3 磷酸化的原因和下游影响
- 批准号:
10606132 - 财政年份:2024
- 资助金额:
$ 20.25万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 20.25万 - 项目类别:
Maternal immune activation remodeling of offspring glycosaminoglycan sulfation patterns during neurodevelopment
神经发育过程中后代糖胺聚糖硫酸化模式的母体免疫激活重塑
- 批准号:
10508305 - 财政年份:2023
- 资助金额:
$ 20.25万 - 项目类别:
Neural activity-based candidate gene identification to link eating disorders and drug addiction
基于神经活动的候选基因识别将饮食失调和药物成瘾联系起来
- 批准号:
10528062 - 财政年份:2023
- 资助金额:
$ 20.25万 - 项目类别:
MAIT cells in lupus skin disease and photosensitivity
MAIT 细胞在狼疮皮肤病和光敏性中的作用
- 批准号:
10556664 - 财政年份:2023
- 资助金额:
$ 20.25万 - 项目类别: